Skip to main content
TipRanks
Go Ultimate75% OFF

HYTN Innovations Inc (HYTN) AI Stock Analysis

5 Followers
TSE:HYTN

HYTN Innovations Inc

(CNQX:HYTN)

Select Model
Rating:42Neutral
Price Target:CAD 0.12▼(-4.17% Downside)
Action:reiterated
Date:10/31/26

The score is held down primarily by weak financial performance (negative gross profit, large losses, ongoing cash burn, and negative equity). Technicals add further pressure with the stock trading below key moving averages and negative MACD. Valuation provides limited support because the negative P/E reflects unprofitability and there is no dividend yield data.

Positive Factors
Revenue GrowthSharp TTM revenue growth demonstrates improving commercial traction and suggests the company is expanding demand for its offerings. If sustained, a larger revenue base could provide operating leverage, support investment in commercialization, and improve the pathway toward more durable earnings.
Negative Factors
Unprofitable OperationsNegative gross profit and deeply negative operating and net margins show that current revenue does not cover the cost base. This limits the benefits of growth, increases reliance on financing or further cost reductions, and leaves profitability vulnerable if commercial expansion fails to improve unit economics.

HYTN Innovations Inc (HYTN) vs. iShares MSCI Canada ETF (EWC)

-50%0%50%100%150%TSE:HYTN0.00%EWC+21.04%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 11.51M
Dividend Yield
―
Average Volume (3M)
15.34K
Price to Earnings (P/E)
-6.4
Beta (1Y)
-1.16
Revenue Growth
194.34%
EPS Growth
75.23%
Country
Canada
Employees
7
Sector
Consumer Defensive
Sector Strength
62
Industry
Beverages - Non-Alcoholic

HYTN Innovations Inc Business Overview & Revenue Model

Company Description

HYTN Innovations Inc. is a Canadian firm engaged in the comprehensive development, manufacturing, marketing, distribution, and sale of cannabis products for the recreational adult-use market. The company's future product line is slated to include a d...

HYTN Innovations Inc Financial Statement Overview

Summary

Despite strong TTM revenue growth (~35% to ~$3.8M) and improving loss/cash-burn trends versus prior years, overall fundamentals remain high-risk: gross profit is slightly negative, operating and net margins are deeply negative (EBIT ~-35%, net ~-47%), operating/free cash flow are still negative (~-$0.6M each), and the balance sheet is stressed with negative shareholders’ equity (~-$1.46M) and ~$1.1M of debt.

Income Statement

18Very Negative

Balance Sheet

12Very Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Sep 2021
Income Statement
Total Revenue3.77M1.67M851.49K763.46K696.36K0
Gross Profit-104.86K93.23K287.44K91.85K121.65K0
EBITDA-1.04M-1.12M-6.26M-1.92M-9.93M-714.47K
Net Income-1.77M-1.52M-6.61M-2.33M-17.38M-959.48K
Balance Sheet
Total Assets2.64M3.62M2.38M2.58M3.79M2.76M
Cash, Cash Equivalents and Short-Term Investments80.15K345.10K256.58K187.56K1.03M264.06K
Total Debt1.10M2.04M793.56K919.74K887.22K2.58M
Total Liabilities4.09M4.74M2.56M2.27M1.71M2.77M
Stockholders Equity-1.46M-1.12M-172.97K314.72K2.07M-8,879
Cash Flow
Free Cash Flow-585.93K-590.49K-804.21K-1.18M-2.38M-1.67M
Operating Cash Flow-573.45K-572.27K-783.36K-1.18M-2.16M-693.52K
Investing Cash Flow-37.16K-15.92K162.67K-4,1002.19M-1.02M
Financing Cash Flow638.11K676.12K689.71K346.17K727.93K1.80M

HYTN Innovations Inc Technical Analysis

Technical Analysis SentimentNegative
Last Price0.12

Price Trends

50DMA0.16Negative
100DMA0.15Negative
200DMA0.19Negative

Market Momentum

MACD-0.01Positive
RSI44.48Neutral
STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 44.48 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HYTN.

HYTN Innovations Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

TSE:HYTN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:CGIITSE:CGII43NeutralCAD 11.16M-6.33152.20%―-27.44%2.57%
TSE:HYTNTSE:HYTN42NeutralCAD 11.51M-6.42148.84%―194.34%75.23%

* Consumer Defensive Sector Average

Performance Comparison

-50%0%50%100%150%TSE:HYTNTSE:CGIITSE:HYPETSE:MUSLTSE:PTFYDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:HYTN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:HYTNHYTN Innovations Inc0.120.000.00%
TSE:CGIICleango Innovations Inc1.230.71136.54%
TSE:HYPEHemp for Health Inc0.15-0.13-44.64%
TSE:MUSLElement Nutritional Sciences Inc0.02-0.03-60.00%
TSE:PTFYPlantify Foods Inc0.09-0.29-76.84%

HYTN Innovations Inc Corporate Events

Business Operations and StrategyExecutive/Board ChangesM&A Transactions

HYTN to Spin Out Peptide Drug Unit into Peptide Development Labs

Positive
Sep 2, 2026

HYTN Innovations Inc., a pharmaceutical manufacturer of psychoactive and psychotropic products including cannabis-derived cannabinoids, serves federally regulated medical markets globally by deploying pharmaceutical-grade development and GMP manufact...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026